Evidence map›Paper›PMID 30616872›Full record

ArticleAmerican journal of kidney diseases : the official journal of the National Kidney Foundation2019

Anemia in Non-Dialysis-Dependent CKD: To Treat or Not to Treat?

Steven Fishbane, Daniel W Ross, Susana Hong

Abstract readEditorialComment

In one paragraph

Article in American journal of kidney diseases : the official journal of the National Kidney Foundation, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it

0cells of the map it votes in

5citing papers in PubMed

–field-weighted citation impact

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

Transgenic augmentation of erythroferrone in mice ameliorates anemia in adenine-induced chronic kidney disease.JCI insight · 2025
Article
Prevalence, incidence, and treatment of anaemia in patients with non-dialysis-dependent chronic kidney disease: findings from a retrospective real-world study in Italy.Journal of nephrology · 2023
Observational
Epidemiology and outcomes in patients with anemia of CKD not on dialysis from a large US healthcare system database: a retrospective observational study.BMC nephrology · 2022
Observational
Low serum iron is associated with anemia in CKD stage 1-4 patients with normal transferrin saturations.Scientific reports · 2021
Article
Safe and Effective Treatment for Anemic Patients With Chronic Kidney Disease: An Updated Systematic Review and Meta-Analysis on Roxadustat.Frontiers in pharmacology · 2021
Article

4 · The record

Corrections and comments

Comment on
Treatment of Anemia With Darbepoetin Prior to Dialysis Initiation and Clinical Outcomes: Analyses From the Trial to Reduce Cardiovascular Events With Aranesp Therapy (TREAT).2019

5 · Who and what money

Authors and funding

3 authors.

Steven FishbaneDivision of Nephrology, Zucker School of Medicine at Hofstra/Northwell, Great Neck, NY. Electronic address: sfishbane@northwell.edu.

Daniel W RossDivision of Nephrology, Zucker School of Medicine at Hofstra/Northwell, Great Neck, NY.

Susana HongDivision of Nephrology, Zucker School of Medicine at Hofstra/Northwell, Great Neck, NY.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AnemiaCardiovascular DiseasesHematinicsRenal Insufficiency, ChronicDarbepoetin alfaHumansRenal DialysisDarbepoetin alfaHematinics

Identifiers

PMID30616872

DOI10.1053/j.ajkd.2018.11.006

What OpenQuestion holds

Textmetadata

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.